GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ikonisys SA (XPAR:ALIKO) » Definitions » Accounts Receivable

Ikonisys (XPAR:ALIKO) Accounts Receivable : €0.32 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Ikonisys Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Ikonisys's accounts receivables for the quarter that ended in Jun. 2024 was €0.32 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Ikonisys's Days Sales Outstanding for the quarter that ended in Jun. 2024 was 192.91.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Ikonisys's Net-Net Working Capital per share for the quarter that ended in Jun. 2024 was €-1.03.


Ikonisys Accounts Receivable Historical Data

The historical data trend for Ikonisys's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ikonisys Accounts Receivable Chart

Ikonisys Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Receivable
0.03 0.03 0.14 0.03 -

Ikonisys Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Accounts Receivable Get a 7-Day Free Trial Premium Member Only 0.12 0.03 0.05 - 0.32

Ikonisys Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.


Ikonisys Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Ikonisys's Days Sales Outstanding for the quarter that ended in Jun. 2024 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0.315/0.298*91
=192.91

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Ikonisys's accounts receivable are only considered to be worth 75% of book value:

Ikonisys's Net-Net Working Capital Per Share for the quarter that ended in Jun. 2024 is calculated as:

Net-Net Working Capital Per Share
=(Cash And Cash Equivalents+0.75 * Accounts Receivable+0.5 * Total Inventories-Total Liabilities
-Preferred Stock-Minority Interest)/Shares Outstanding (EOP)
=(0.022+0.75 * 0.315+0.5 * 0.941-11.755
-0-0)/10.718
=-1.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.


Ikonisys Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Ikonisys's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Ikonisys Business Description

Traded in Other Exchanges
N/A
Address
62 Rue de Caumartin, Paris, FRA, 75009
Ikonisys SA is specialized in the design, manufacture and marketing of medical diagnostic equipment. The company offers cell diagnostic products in the fields of cancer diagnosis, detection of genetic disorders, and fertility testing.

Ikonisys Headlines

No Headlines